Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

More in Allergy & Clinical Immunology

A new study in The New England Journal of Medicine evaluates the efficacy of dupilumab, a drug being developed by Sanofi and Regeneron Pharmaceuticals, in patients with persistent, moderate-to-severe asthma and elevated eosinophil levels. “Three patients had an asthma exacerbation with dupilumab (6%)...
An article in Bloomberg News reports “Two drugs from Bristol-Myers Squibb Co. (BMY) shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.” A study found the amount of...
Immune stimulation by microbes transferred from parents to infants via pacifiers is thought to reduce risk of allergy development, and a new study in Pediatrics investigates whether pacifier cleaning practices affect the risk. Researchers found that “Children whose parents ‘cleaned’ their pacifier by...